Filing Details
- Accession Number:
- 0000950170-25-026691
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-25 16:16:47
- Reporting Period:
- 2025-02-21
- Filing Date:
- 2025-02-25
- Accepted Time:
- 2025-02-25 16:16:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1108109 | Community Health Systems Inc | CYH | Services-General Medical & Surgical Hospitals, Nec (8062) | 133893191 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2044704 | S Miguel Benet | 4000 Meridian Boulevard Franklin TN 37067 | President And Cmo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-21 | 23,875 | $3.53 | 55,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Based Restricted | $0.00 | 15,000 | 15,000 | Direct | ||
| Common Stock | Performance Based Restricted | $0.00 | 30,000 | 30,000 | Direct | ||
| Common Stock | Performance Based Restricted | $0.00 | 30,000 | 30,000 | Direct | ||
| Common Stock | Stock Options (Right to Buy) | $10.18 | 2023-03-01 | 2032-02-29 | 15,000 | 15,000 | Direct |
| Common Stock | Stock Options (Right to Buy) | $6.15 | 2024-03-01 | 2033-02-28 | 30,000 | 30,000 | Direct |
| Common Stock | Stock Options (Right to Buy) | $2.87 | 2025-03-01 | 2034-02-28 | 30,000 | 30,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 15,000 | 15,000 | Direct | |
| 30,000 | 30,000 | Direct | |
| 30,000 | 30,000 | Direct | |
| 2032-02-29 | 15,000 | 15,000 | Direct |
| 2033-02-28 | 30,000 | 30,000 | Direct |
| 2034-02-28 | 30,000 | 30,000 | Direct |
Footnotes
- These shares were sold in a series of transactions at a sales price of $3.525 per share.
- The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
- The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
- The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
- Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
Billionaire Hedge Funds
